This stock has been one of the best winners in healthcare over the past few years, in terms of company health, profitability and correlation to stock price action.
All the same, just like with
A
, the current market uncertainty has left the stock here in a wedge pattern after its earnings report.
Even though the earnings beat estimates, it was not better than the prior growth experienced and so combined with the overbought nature of the stock, this could be a sign that the stock is topping out at least for now.
In short, if the company fails to keep growing, fear could set in and investors will go ahead to ease off the gas pedal, leading to a possible bearish trend.
For now, I am looking for a bearish drift after earnings, but I look to stay longer if a bearish trend develops; losses will be cut quickly.
Stop @ 242.18
Target @ 227.79
All the same, just like with
A
, the current market uncertainty has left the stock here in a wedge pattern after its earnings report. Even though the earnings beat estimates, it was not better than the prior growth experienced and so combined with the overbought nature of the stock, this could be a sign that the stock is topping out at least for now.
In short, if the company fails to keep growing, fear could set in and investors will go ahead to ease off the gas pedal, leading to a possible bearish trend.
For now, I am looking for a bearish drift after earnings, but I look to stay longer if a bearish trend develops; losses will be cut quickly.
Stop @ 242.18
Target @ 227.79
